Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity

被引：114

作者：

Roppe, J ^{[1
]}

Smith, ND ^{[1
]}

Huang, DH ^{[1
]}

Tehrani, L ^{[1
]}

Wang, BW ^{[1
]}

Anderson, J ^{[1
]}

Brodkin, J ^{[1
]}

Chung, J ^{[1
]}

Jiang, XH ^{[1
]}

King, C ^{[1
]}

Munoz, B ^{[1
]}

Varney, MA ^{[1
]}

Prasit, P ^{[1
]}

Cosford, NDP ^{[1
]}

机构：

[1] Merck Res Labs, San Diego, CA 92121 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2004年 / 47卷 / 19期

关键词：

D O I：

10.1021/jm049828c

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The highly potent, selective, and brain-penetrant metabotropic glutamate subtype 5 (mGlu5) receptor antagonists 3-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitrile (47) and 3-fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitrile (48) are reported. Compound 47 is active in the rat fear-potentiated startle (FPS) model of anxiety with ED50 = 5.4 mg/kg (po) when dosed acutely. In this model the anxiolytic effects of 47 rapidly tolerate on repeated dosing.

引用

页码：4645 / 4648

页数：4

共 50 条

[1] Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists
Kulkarni, Santosh S.
Newman, Amy Hauck
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (11) : 2987 - 2991
[2] Discovery of novel modulators of metabotropic glutamate receptor subtype-5
Wang, BW
Vernier, JM
Rao, S
Chung, J
Anderson, JJ
Brodkin, JD
Jiang, XH
Gardner, MF
Yang, XQ
Munoz, B
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (01) : 17 - 21
[3] Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP
Lea, Paul M., IV
Faden, Alan I.
CNS DRUG REVIEWS, 2006, 12 (02): : 149 - 166
[4] Design and synthesis of novel heterobiaryl amides as metabotropic glutamate receptor subtype 5 antagonists
Kulkarni, Santosh S.
Newman, Amy Hauck
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) : 2074 - 2079
[5] Design and synthesis of noncompetitive metabotropic glutamate receptor subtype 5 antagonists
Kulkarni, Santosh S.
Nightingale, Barbara
Dersch, Christina M.
Rothman, Richard B.
Newman, Amy Hauck
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (13) : 3371 - 3375
[6] Dipyridyl amines: Potent metabotropic glutamate subtype 5 receptor antagonists
Kamenecka, TM
Bonnefous, C
Govek, S
Vernier, JM
Hutchinson, J
Chung, J
Reyes-Manalo, G
Anderson, JJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (19) : 4350 - 4353
[7] Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity
Rodriguez, Alice L.
Grier, Mark D.
Jones, Carrie K.
Herman, Elizabeth J.
Kane, Alexander S.
Smith, Randy L.
Williams, Richard
Zhou, Ya
Marlo, Joy E.
Days, Emily L.
Blatt, Tasha N.
Jadhav, Satyawan
Menon, Usha N.
Vinson, Paige N.
Rook, Jerri M.
Stauffer, Shaun R.
Niswender, Colleen M.
Lindsley, Craig W.
Weaver, C. David
Conn, P. Jeffrey
MOLECULAR PHARMACOLOGY, 2010, 78 (06) : 1105 - 1123
[8] Antagonists at Metabotropic Glutamate Receptor Subtype 5 Structure Activity Relationships and Therapeutic Potential for Addiction
Carroll, F. Ivy
ADDICTION REVIEWS 2008, 2008, 1141 : 221 - 232
[9] Synthesis and Evaluation of Metabotropic Glutamate Receptor Subtype 5 Antagonists Based on Fenobam
Gichinga, Moses G.
Olson, Jeremy P.
Butala, Elizabeth
Navarro, Hernan A.
Gilmour, Brian P.
Mascarella, S. Wayne
Carroll, F. Ivy
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (12): : 882 - 884
[10] Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents
Engers, Julie L.
Rodriguez, Alice L.
Konkol, Leah C.
Morrison, Ryan D.
Thompson, Analisa D.
Byers, Frank W.
Blobaum, Anna L.
Chang, Sichen
Venable, Daryl F.
Loch, Matthew T.
Niswender, Colleen M.
Daniels, J. Scott
Jones, Carrie K.
Conn, P. Jeffrey
Lindsley, Craig W.
Emmitte, Kyle A.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (18) : 7485 - 7500

← 1 2 3 4 5 →